Skip to main content
Erschienen in: World Journal of Surgery 9/2008

01.09.2008

Impact of the Degree of Liver Resection on Survival for Patients with Multiple Liver Metastases from Colorectal Cancer

verfasst von: Kuniya Tanaka, Hiroshi Shimada, Chizuru Matsumoto, Kenichi Matsuo, Kazuhisa Takeda, Yasuhiko Nagano, Shinji Togo

Erschienen in: World Journal of Surgery | Ausgabe 9/2008

Einloggen, um Zugang zu erhalten

Abstract

Background

Although the degree of hepatic resection has been found to be a key aspect of tumor stimulation, the differences in clinical outcome between a massive liver resection and a less extensive resection for multiple colorectal metastases have not been well studied. The purpose of this study was to clarify the impact of the extent of liver resection on survival outcome.

Methods

Clinicopathologic data were available for 85 patients who were surgically treated for four or more liver metastases. Forty-nine patients who underwent a major hepatic resection were compared with patients who underwent minor hepatic resections (n = 36).

Results

As the patients undergoing major resection were more likely to have multiple (p = 0.014) and large tumors (p = 0.021) compared to the minor-resection patients, their overall survival was worse (p = 0.046) and the disease-free rate tended to be poorer. By multivariate analysis of the cohorts, the only independent factor affecting survival was the number of liver tumors (≤5 or ≥6; relative risk [RR] = 0.427; p = 0.014). When patients with six or more metastases were selected and analyzed, the overall survival of patients who had a major resection was significantly poorer than those who had minor resections (p = 0.028), although the clinical characteristics were comparable between the two groups.

Conclusion

Although the extent of hepatectomy was not an independent prognosticator, minor resections for multiple colorectal metastases may offer a long-term survival advantage compared to a major resection.
Literatur
1.
Zurück zum Zitat Registry of Hepatic Metastases (1988) Resection of the liver for colorectal carcinoma metastases: a multiinstitutional study of indications for resection. Surgery 103:278–288 Registry of Hepatic Metastases (1988) Resection of the liver for colorectal carcinoma metastases: a multiinstitutional study of indications for resection. Surgery 103:278–288
2.
Zurück zum Zitat Minagawa M, Makuuchi M, Torzilli G et al (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231:487–499PubMedCrossRef Minagawa M, Makuuchi M, Torzilli G et al (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231:487–499PubMedCrossRef
3.
Zurück zum Zitat Shaw IM, Rees M, Welsh KS et al (2006) Repeat hepatic resection for recurrent colorectal liver metastases is associated with favorable long-term survival. Br J Surg 93:457–464PubMedCrossRef Shaw IM, Rees M, Welsh KS et al (2006) Repeat hepatic resection for recurrent colorectal liver metastases is associated with favorable long-term survival. Br J Surg 93:457–464PubMedCrossRef
4.
Zurück zum Zitat Arru M, Aldrighetti L, Castoldi R et al (2007) Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer. World J Surg 32:93–103CrossRef Arru M, Aldrighetti L, Castoldi R et al (2007) Analysis of prognostic factors influencing long-term survival after hepatic resection for metastatic colorectal cancer. World J Surg 32:93–103CrossRef
5.
Zurück zum Zitat Fortner JG, Silva JS, Golbey RB et al (1984) Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 199:306–316PubMedCrossRef Fortner JG, Silva JS, Golbey RB et al (1984) Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. I. Treatment by hepatic resection. Ann Surg 199:306–316PubMedCrossRef
6.
Zurück zum Zitat August DA, Ottow RT, Sugarbaker PH (1984) Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev 3:303–324PubMedCrossRef August DA, Ottow RT, Sugarbaker PH (1984) Clinical perspective of human colorectal cancer metastasis. Cancer Metastasis Rev 3:303–324PubMedCrossRef
7.
Zurück zum Zitat Broering DC, Hillert C, Krupski G et al (2002) Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg 6:905–913PubMedCrossRef Broering DC, Hillert C, Krupski G et al (2002) Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg 6:905–913PubMedCrossRef
8.
Zurück zum Zitat Abdalla EK, Hicks ME, Vauthey JN (2001) Portal vein embolization: rationale, technique and future prospects. Br J Surg 88:165–175PubMedCrossRef Abdalla EK, Hicks ME, Vauthey JN (2001) Portal vein embolization: rationale, technique and future prospects. Br J Surg 88:165–175PubMedCrossRef
9.
Zurück zum Zitat Athoulay D, Castaing D, Smail A et al (2000) Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231:480–486CrossRef Athoulay D, Castaing D, Smail A et al (2000) Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231:480–486CrossRef
10.
Zurück zum Zitat Adam R, Laurent A, Azoulay D et al (2000) Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 232:777–785PubMedCrossRef Adam R, Laurent A, Azoulay D et al (2000) Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Ann Surg 232:777–785PubMedCrossRef
11.
Zurück zum Zitat Kianmanesh R, Farges O, Abdalla EK et al (2003) Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg 197:164–170PubMedCrossRef Kianmanesh R, Farges O, Abdalla EK et al (2003) Right portal vein ligation: a new planned two-step all-surgical approach for complete resection of primary gastrointestinal tumors with multiple bilateral liver metastases. J Am Coll Surg 197:164–170PubMedCrossRef
12.
Zurück zum Zitat Ikeda Y, Matsumata T, Takenaka K et al (1995) Preliminary report of tumor metastasis during liver regeneration after hepatic resection in rats. Eur J Surg Oncol 21:188–190PubMedCrossRef Ikeda Y, Matsumata T, Takenaka K et al (1995) Preliminary report of tumor metastasis during liver regeneration after hepatic resection in rats. Eur J Surg Oncol 21:188–190PubMedCrossRef
13.
Zurück zum Zitat Mizutani J, Hiraoka T, Yamashita R et al (1992) Promotion of hepatic metastases by liver resection in the rat. Br J Cancer 65:794–797PubMed Mizutani J, Hiraoka T, Yamashita R et al (1992) Promotion of hepatic metastases by liver resection in the rat. Br J Cancer 65:794–797PubMed
14.
Zurück zum Zitat Jiang W, Hiscox S, Matsumoto K et al (1999) Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit Rev Oncol Hematol 29:209–248PubMedCrossRef Jiang W, Hiscox S, Matsumoto K et al (1999) Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer. Crit Rev Oncol Hematol 29:209–248PubMedCrossRef
15.
Zurück zum Zitat Lukomska B, Dluzniewska J, Polanski J et al (2004) Expression of growth factors in colorectal carcinoma liver metastatic patients after partial hepatectomy: implications for a functional role in cell proliferation during liver regeneration. Comp Hepatol 3(Suppl 1):S52PubMedCrossRef Lukomska B, Dluzniewska J, Polanski J et al (2004) Expression of growth factors in colorectal carcinoma liver metastatic patients after partial hepatectomy: implications for a functional role in cell proliferation during liver regeneration. Comp Hepatol 3(Suppl 1):S52PubMedCrossRef
16.
Zurück zum Zitat Yoon SS, Kim SH, Gonen M et al (2006) Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol 13:353–362PubMedCrossRef Yoon SS, Kim SH, Gonen M et al (2006) Profile of plasma angiogenic factors before and after hepatectomy for colorectal cancer liver metastases. Ann Surg Oncol 13:353–362PubMedCrossRef
17.
Zurück zum Zitat Hemming AW, Reed AI, Howard RJ et al (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237:686–693PubMedCrossRef Hemming AW, Reed AI, Howard RJ et al (2003) Preoperative portal vein embolization for extended hepatectomy. Ann Surg 237:686–693PubMedCrossRef
18.
Zurück zum Zitat Barbaro B, Di Stasi C, Nuzzo G et al (2003) Preoperative right portal vein embolization in patients with metastatic liver disease. Metastatic liver volumes after RPVE. Acta Radiol 44:98–102PubMedCrossRef Barbaro B, Di Stasi C, Nuzzo G et al (2003) Preoperative right portal vein embolization in patients with metastatic liver disease. Metastatic liver volumes after RPVE. Acta Radiol 44:98–102PubMedCrossRef
19.
Zurück zum Zitat Kokudo N, Tada K, Seki M et al (2001) Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 34:267–272PubMedCrossRef Kokudo N, Tada K, Seki M et al (2001) Proliferative activity of intrahepatic colorectal metastases after preoperative hemihepatic portal vein embolization. Hepatology 34:267–272PubMedCrossRef
20.
Zurück zum Zitat Yamanaka N, Okamoto E, Oriyama T et al (1994) A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg 219:342–346PubMedCrossRef Yamanaka N, Okamoto E, Oriyama T et al (1994) A prediction scoring system to select the surgical treatment of liver cancer. Further refinement based on 10 years of use. Ann Surg 219:342–346PubMedCrossRef
21.
Zurück zum Zitat The Brisbane (2000) Terminology of Liver Anatomy and Resection (2000) Terminology Committee of the International Hepato-Pancreato-Biliary Association. HPB 2:333–339 The Brisbane (2000) Terminology of Liver Anatomy and Resection (2000) Terminology Committee of the International Hepato-Pancreato-Biliary Association. HPB 2:333–339
22.
Zurück zum Zitat Elias D, Ouellet JF, Bellon N et al (2003) Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 90:567–574PubMedCrossRef Elias D, Ouellet JF, Bellon N et al (2003) Extrahepatic disease does not contraindicate hepatectomy for colorectal liver metastases. Br J Surg 90:567–574PubMedCrossRef
23.
Zurück zum Zitat Harun N, Nikfarjam M, Muralidharan V et al (2007) Liver regeneration stimulates tumor metastases. J Surg Res 138:284–290PubMedCrossRef Harun N, Nikfarjam M, Muralidharan V et al (2007) Liver regeneration stimulates tumor metastases. J Surg Res 138:284–290PubMedCrossRef
24.
Zurück zum Zitat Jiang WG, Hallett MB, Puntis MC (1993) Hepatocyte growth factor/scatter factor, liver regeneration and cancer metastasis. Br J Surg 80:1368–1373PubMedCrossRef Jiang WG, Hallett MB, Puntis MC (1993) Hepatocyte growth factor/scatter factor, liver regeneration and cancer metastasis. Br J Surg 80:1368–1373PubMedCrossRef
25.
Zurück zum Zitat Castillo MH, Doerr RJ, Paolini N Jr et al (1989) Hepatectomy prolongs survival of mice with induced liver metastases. Arch Surg 124:167–169PubMed Castillo MH, Doerr RJ, Paolini N Jr et al (1989) Hepatectomy prolongs survival of mice with induced liver metastases. Arch Surg 124:167–169PubMed
26.
Zurück zum Zitat Doerr R, Castillo M, Evans P et al (1989) Partial hepatectomy augments the liver’s antitumor response. Arch Surg 124:170–174PubMed Doerr R, Castillo M, Evans P et al (1989) Partial hepatectomy augments the liver’s antitumor response. Arch Surg 124:170–174PubMed
27.
Zurück zum Zitat Ono M, Tanaka N, Orita K (1986) Complete regression of mouse hepatoma transplanted after partial hepatectomy and the immunological mechanism of such regression. Cancer Res 46:5049–5053PubMed Ono M, Tanaka N, Orita K (1986) Complete regression of mouse hepatoma transplanted after partial hepatectomy and the immunological mechanism of such regression. Cancer Res 46:5049–5053PubMed
29.
Zurück zum Zitat Mangnall D, Bird NC, Majeed AW (2003) The molecular physiology of liver regeneration following partial hepatectomy. Liver Int 23:124–138PubMedCrossRef Mangnall D, Bird NC, Majeed AW (2003) The molecular physiology of liver regeneration following partial hepatectomy. Liver Int 23:124–138PubMedCrossRef
30.
Zurück zum Zitat Elias D, De Baere T, Roche A et al (1999) During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 86:784–788PubMedCrossRef Elias D, De Baere T, Roche A et al (1999) During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Br J Surg 86:784–788PubMedCrossRef
31.
Zurück zum Zitat Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients. Cancer 77:1254–1262PubMedCrossRef Nordlinger B, Guiguet M, Vaillant JC et al (1996) Surgical resection of colorectal carcinoma metastases to the liver: a prognostic scoring system to improve case selection, based on 1568 patients. Cancer 77:1254–1262PubMedCrossRef
32.
Zurück zum Zitat Tanaka K, Shimada H, Kubota K et al (2005) Effectiveness of prehepatectomy intra-arterial chemotherapy for multiple bilobar colorectal cancer metastases to the liver: a clinicopathologic study of peritumoral vasculobiliary invasion. Surgery 137:156–164PubMedCrossRef Tanaka K, Shimada H, Kubota K et al (2005) Effectiveness of prehepatectomy intra-arterial chemotherapy for multiple bilobar colorectal cancer metastases to the liver: a clinicopathologic study of peritumoral vasculobiliary invasion. Surgery 137:156–164PubMedCrossRef
33.
Zurück zum Zitat Kornprat P, Jarnagin WR, Gonen M et al (2007) Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol 14:1151–1160PubMedCrossRef Kornprat P, Jarnagin WR, Gonen M et al (2007) Outcome after hepatectomy for multiple (four or more) colorectal metastases in the era of effective chemotherapy. Ann Surg Oncol 14:1151–1160PubMedCrossRef
34.
Zurück zum Zitat Weber SM, Jarnagin WR, DeMatteo RP et al (2000) Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 7:643–650PubMedCrossRef Weber SM, Jarnagin WR, DeMatteo RP et al (2000) Survival after resection of multiple hepatic colorectal metastases. Ann Surg Oncol 7:643–650PubMedCrossRef
35.
Zurück zum Zitat Abdalla EK, Vauthey JN, Ellis LM et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818–827PubMedCrossRef Abdalla EK, Vauthey JN, Ellis LM et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239:818–827PubMedCrossRef
36.
Zurück zum Zitat Tanaka K, Shimada H, Nagano Y et al (2006) Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. Surgery 139:263–273PubMedCrossRef Tanaka K, Shimada H, Nagano Y et al (2006) Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver. Surgery 139:263–273PubMedCrossRef
37.
Zurück zum Zitat Giacchetti S, Perpoint B, Zidani R et al (2000) Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 18:136–147PubMed Giacchetti S, Perpoint B, Zidani R et al (2000) Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer. J Clin Oncol 18:136–147PubMed
38.
Zurück zum Zitat Douillard JY, Cunningham D, Roth AD et al (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355:1041–1047PubMedCrossRef Douillard JY, Cunningham D, Roth AD et al (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet 355:1041–1047PubMedCrossRef
39.
Zurück zum Zitat Bismuth H, Adam R, Levi F et al (1996) Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224:509–520PubMedCrossRef Bismuth H, Adam R, Levi F et al (1996) Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224:509–520PubMedCrossRef
40.
Zurück zum Zitat Adam R, Avisar E, Ariche A et al (2001) Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal [liver] metastases. Ann Surg Oncol 8:347–353PubMedCrossRef Adam R, Avisar E, Ariche A et al (2001) Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal [liver] metastases. Ann Surg Oncol 8:347–353PubMedCrossRef
41.
Zurück zum Zitat Parikh AA, Gentner B, Wu TT et al (2003) Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg 7:1082–1088PubMedCrossRef Parikh AA, Gentner B, Wu TT et al (2003) Perioperative complications in patients undergoing major liver resection with or without neoadjuvant chemotherapy. J Gastrointest Surg 7:1082–1088PubMedCrossRef
42.
Zurück zum Zitat Tanaka K, Shimada H, Ueda M et al (2006) Perioperative complications after hepatectomy with or without intra-arterial chemotherapy for bilobar colorectal cancer liver metastases. Surgery 139:599–607PubMedCrossRef Tanaka K, Shimada H, Ueda M et al (2006) Perioperative complications after hepatectomy with or without intra-arterial chemotherapy for bilobar colorectal cancer liver metastases. Surgery 139:599–607PubMedCrossRef
43.
Zurück zum Zitat Karoui M, Penna C, Amin-Hashem M et al (2006) Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243:1–7PubMedCrossRef Karoui M, Penna C, Amin-Hashem M et al (2006) Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243:1–7PubMedCrossRef
44.
Zurück zum Zitat Lorenz M, Müller H, Schramm H et al (1998) Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. Ann Surg 228:756–764PubMedCrossRef Lorenz M, Müller H, Schramm H et al (1998) Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. Ann Surg 228:756–764PubMedCrossRef
45.
Zurück zum Zitat Onaitis M, Morse M, Hurwitz H et al (2003) Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastases. Ann Surg 237:782–789PubMedCrossRef Onaitis M, Morse M, Hurwitz H et al (2003) Adjuvant hepatic arterial chemotherapy following metastasectomy in patients with isolated liver metastases. Ann Surg 237:782–789PubMedCrossRef
46.
Zurück zum Zitat Kemeny NE, Niedzwiecki D, Hollis DR et al (2006) Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 24:1395–1403PubMedCrossRef Kemeny NE, Niedzwiecki D, Hollis DR et al (2006) Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: a randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 24:1395–1403PubMedCrossRef
47.
Zurück zum Zitat Kemeny N, Huang Y, Cohen AM et al (1999) Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341:2039–2048PubMedCrossRef Kemeny N, Huang Y, Cohen AM et al (1999) Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 341:2039–2048PubMedCrossRef
48.
Zurück zum Zitat Benoist S, Brouquet A, Penna C et al (2006) Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24:3939–3945PubMedCrossRef Benoist S, Brouquet A, Penna C et al (2006) Complete response of colorectal liver metastases after chemotherapy: does it mean cure? J Clin Oncol 24:3939–3945PubMedCrossRef
Metadaten
Titel
Impact of the Degree of Liver Resection on Survival for Patients with Multiple Liver Metastases from Colorectal Cancer
verfasst von
Kuniya Tanaka
Hiroshi Shimada
Chizuru Matsumoto
Kenichi Matsuo
Kazuhisa Takeda
Yasuhiko Nagano
Shinji Togo
Publikationsdatum
01.09.2008
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 9/2008
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-008-9610-0

Weitere Artikel der Ausgabe 9/2008

World Journal of Surgery 9/2008 Zur Ausgabe

Häusliche Gewalt in der orthopädischen Notaufnahme oft nicht erkannt

28.05.2024 Häusliche Gewalt Nachrichten

In der Notaufnahme wird die Chance, Opfer von häuslicher Gewalt zu identifizieren, von Orthopäden und Orthopädinnen offenbar zu wenig genutzt. Darauf deuten die Ergebnisse einer Fragebogenstudie an der Sahlgrenska-Universität in Schweden hin.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

TAVI versus Klappenchirurgie: Neue Vergleichsstudie sorgt für Erstaunen

21.05.2024 TAVI Nachrichten

Bei schwerer Aortenstenose und obstruktiver KHK empfehlen die Leitlinien derzeit eine chirurgische Kombi-Behandlung aus Klappenersatz plus Bypass-OP. Diese Empfehlung wird allerdings jetzt durch eine aktuelle Studie infrage gestellt – mit überraschender Deutlichkeit.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.